Response to Editorial Comment to Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital

被引:0
|
作者
Patel, Devin N. [1 ]
Chapin, Brian F. [2 ]
Freedland, Stephen J. [1 ,3 ]
机构
[1] Cedars Sinai Med Ctr, Div Urol, Los Angeles, CA 90048 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[3] Vet Affairs Med Ctr, Div Urol, Durham, NC 27705 USA
关键词
D O I
10.1111/iju.13861
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1005 / 1005
页数:1
相关论文
共 50 条
  • [21] Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database
    Vidal, Adriana C.
    Howard, Lauren E.
    de Hoedt, Amanda
    Kane, Christopher J.
    Terris, Martha K.
    Aronson, William J.
    Cooperberg, Matthew R.
    Amling, Christopher L.
    Freedland, Stephen J.
    BJU INTERNATIONAL, 2018, 122 (01) : 76 - 82
  • [22] Circulating Tumor Cells Predict Survival Benefit From Treatment in Metastatic Castration-Resistant Prostate Cancer Editorial Comment
    de Bono, J. S.
    Scher, H. I.
    Montgomery, R. B.
    Parker, C.
    Miller, M. C.
    Tissing, H.
    Doyle, G. V.
    Terstappen, L. W.
    Pienta, K. J.
    Raghavan, D.
    JOURNAL OF UROLOGY, 2009, 181 (06): : 2535 - 2536
  • [23] The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study
    Okita, Kazutaka
    Hatakeyama, Shingo
    Narita, Shintaro
    Takahashi, Masahiro
    Sakurai, Toshihiko
    Kawamura, Sadafumi
    Hoshi, Senji
    Ishida, Masanori
    Kawaguchi, Toshiaki
    Ishidoya, Shigeto
    Shimoda, Jiro
    Sato, Hiromi
    Mitsuzuka, Koji
    Ito, Akihiro
    Tsuchiya, Norihiko
    Arai, Yoichi
    Habuchi, Tomonori
    Ohyama, Chikara
    CLINICAL GENITOURINARY CANCER, 2020, 18 (02) : E103 - E111
  • [24] Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223
    Roviello, Giandomenico
    Gallicchio, Rosj
    Bozza, Giovanni
    Rodriquenz, Maria Grazia
    Aieta, Michele
    Storto, Giovanni
    ONCOTARGETS AND THERAPY, 2019, 12 : 9 - 13
  • [25] Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry
    Francini, Edoardo
    Gray, Kathryn P.
    Shaw, Grace K.
    Evan, Carolyn P.
    Hamid, Anis A.
    Perry, Caitlin E.
    Kantoff, Philip W.
    Taplin, Mary-Ellen
    Sweeney, Christopher J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (03) : 420 - 427
  • [26] Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry
    Edoardo Francini
    Kathryn P. Gray
    Grace K. Shaw
    Carolyn P. Evan
    Anis A. Hamid
    Caitlin E. Perry
    Philip W. Kantoff
    Mary-Ellen Taplin
    Christopher J. Sweeney
    Prostate Cancer and Prostatic Diseases, 2019, 22 : 420 - 427
  • [27] The effect of treatment sequence on overall survival for men with metastatic castration-resistant prostate cancer: A multicenter retrospective study
    Hatakeyama, Shingo
    Okita, Kazutaka
    Yamamoto, Hayato
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [28] Treatment patterns and overall survival among men with metastatic castration-resistant prostate cancer harboring DDR mutations
    Solit, David B.
    Mettu, Niharika B.
    McCall, Shannon J.
    Dhawan, Mallika
    Bobbili, Priyanka J.
    DerSarkissian, Maral
    Ivanova, Jasmina
    Arondekar, Bhakti
    Chang, Jane
    Niyazov, Alexander
    Lee, Jocelyn
    Huq, Risha
    Green, Michelle
    Turski, Michelle
    Muthukumar, Aruna
    Guo, Tracy
    Duh, Mei Sheng
    Oh, William K.
    CANCER RESEARCH, 2023, 83 (07)
  • [29] Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?
    L E Howard
    A M De Hoedt
    W J Aronson
    C J Kane
    C L Amling
    M R Cooperberg
    M K Terris
    C H Divers
    A Valderrama
    S J Freedland
    Prostate Cancer and Prostatic Diseases, 2016, 19 : 380 - 384
  • [30] Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?
    Howard, L. E.
    De Hoedt, A. M.
    Aronson, W. J.
    Kane, C. J.
    Amling, C. L.
    Cooperberg, M. R.
    Terris, M. K.
    Divers, C. H.
    Valderrama, A.
    Freedland, S. J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2016, 19 (04) : 380 - 384